Screener
Repligen RGEN Compensation and benefits
Compensation and benefits at other companies
Other financials
Where this comes from
Reported directly by Repligen in its filing.
Tagged under the XBRL concept us-gaap:ShareBasedCompensation.
The source filing: Repligen’s 10-Q, filed July 29, 2026.
- Filed
- Jul 29, 2026, 4:19 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001193125-26-323773
| Line item | Six Months Ended June 30, 2026 | Six Months Ended June 30, 2025 |
|---|---|---|
| Depreciation and amortization | 38,824 | 38,785 |
| Amortization of debt discount and issuance costs | 8,833 | 8,158 |
| Loss on sale of business | 13,660 | — |
| Stock-based compensation | 16,335 | 15,648 |
| Deferred income taxes, net | (4,775) | (2,569) |
| Change in fair value of contingent consideration | 2,162 | (7,939) |
| Net unrealized foreign exchange gain | (119) | (12,253) |
| Operating lease right of use asset amortization | 9,486 | 9,169 |
ITEM 1. Financial Statements
FAQ
- What is Repligen's compensation and benefits?
- Repligen (RGEN) reported compensation and benefits of $377K in Q2 2026.
- How has Repligen's compensation and benefits changed year-over-year?
- Repligen's compensation and benefits decreased by 95.5% year-over-year, from $8.38M to $377K.
- What is the long-term trend for Repligen's compensation and benefits?
- Over 2 years (2021 to 2023), Repligen's compensation and benefits has grown at a -3.6% compound annual growth rate (CAGR), from $27.5M to $25.58M.
- What does compensation and benefits mean?
- Total employee-related costs including salaries, wages, bonuses, commissions, stock-based compensation, health insurance, retirement contributions, and payroll taxes.
Ask your AI about Repligen's compensation and benefits.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude